Bank of New York Mellon Corp - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 158 filers reported holding KRYSTAL BIOTECH INC in Q4 2022. The put-call ratio across all filers is 6.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$11,393,520
+0.4%
98,220
+1.7%
0.00%
+50.0%
Q2 2023$11,342,718
+78.1%
96,616
+21.4%
0.00%
+100.0%
Q1 2023$6,369,814
-2.1%
79,563
-3.1%
0.00%0.0%
Q4 2022$6,503,645
+10.1%
82,096
-3.2%
0.00%0.0%
Q3 2022$5,908,000
+12.1%
84,792
+5.6%
0.00%0.0%
Q2 2022$5,270,000
-8.9%
80,263
-7.6%
0.00%0.0%
Q1 2022$5,782,000
-0.9%
86,895
+4.1%
0.00%0.0%
Q4 2021$5,837,000
+46.3%
83,451
+9.2%
0.00%0.0%
Q3 2021$3,991,000
-16.9%
76,429
+8.2%
0.00%0.0%
Q2 2021$4,802,000
-7.5%
70,630
+4.8%
0.00%0.0%
Q1 2021$5,189,000
+28.1%
67,368
-0.2%
0.00%0.0%
Q4 2020$4,050,000
+50.7%
67,480
+8.1%
0.00%0.0%
Q3 2020$2,687,000
+10.1%
62,415
+5.9%
0.00%0.0%
Q2 2020$2,440,000
-13.5%
58,913
-9.7%
0.00%0.0%
Q1 2020$2,821,000
-24.6%
65,220
-3.5%
0.00%0.0%
Q4 2019$3,743,000
+48.5%
67,589
-6.9%
0.00%0.0%
Q3 2019$2,521,000
-3.3%
72,616
+12.2%
0.00%0.0%
Q2 2019$2,606,000
+279.3%
64,726
+210.2%
0.00%
Q1 2019$687,000
+33.9%
20,867
-15.4%
0.00%
Q4 2018$513,00024,6770.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q4 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 2,003,367$232,390,57211.06%
Frazier Life Sciences Management, L.P. 988,460$114,661,3607.62%
S Squared Technology, LLC 108,215$12,552,9406.77%
Avoro Capital Advisors LLC 2,565,555$297,604,3804.64%
APIS CAPITAL ADVISORS, LLC 24,000$2,784,0003.61%
Nicholas Investment Partners, LP 355,611$41,250,8763.08%
Ghost Tree Capital, LLC 80,000$9,280,0003.05%
SILVERARC CAPITAL MANAGEMENT, LLC 71,531$8,297,5962.52%
Affinity Asset Advisors, LLC 57,500$6,670,0001.88%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 46,092$5,344,8281.80%
View complete list of KRYSTAL BIOTECH INC shareholders